Stanford University Cancer Center is a clinical research site located in Stanford, California, United States 94305.
Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.
Stanford University Cancer Center has participated in 10 clinical trials.
Therapeutic areas: Persistent or Recurrent Cutaneous T-Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic Syndromes.
Sponsors: Eisai Inc., Celgene, Traws Pharma, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Stanford
Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford University Cancer Center has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford University Cancer Center has 10 clinical trials on record. Their work covers Persistent or Recurrent Cutaneous T-Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic Syndromes.
Stanford University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.